Clinical Trial Update: Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of CBX129801 in patients with Type 1 diabetes and diabetic peripheral neuropathy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• CBX129801

Snippet

Sponsor: Cebix Incorporated | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED